PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of agingLink to Publisher's site
 
Aging (Albany NY). Feb 2011; 3(2): 102–107.
Published online Feb 28, 2011.
PMCID: PMC3082006
Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress
Ozkan Ozden,1 Seong-Hoon Park,1 Hyun-Seok Kim,1 Haiyan Jiang,1 Mitchell C. Coleman,2 Douglas R. Spitz,2 and David Gius1
1 Departments of Cancer Biology, Pediatrics, and Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN 37232, USA
2 Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA 52242, USA
Corresponding author: David Gius, MD, PhD; David.Gius/at/vanderbilt.edu
Received February 24, 2011; Accepted February 27, 2011.
A fundamental observation in biology is that mitochondrial function, as measured by increased reactive oxygen species (ROS), changes significantly with age, suggesting a potential mechanistic link between the cellular processes governing longevity and mitochondrial metabolism homeostasis. In addition, it is well established that altered ROS levels are observed in multiple age-related illnesses including carcinogenesis, neurodegenerative, fatty liver, insulin resistance, and cardiac disease, to name just a few. Manganese superoxide dismutase (MnSOD) is the primary mitochondrial ROS scavenging enzyme that converts superoxide to hydrogen peroxide, which is subsequently converted to water by catalase and other peroxidases. It has recently been shown that MnSOD enzymatic activity is regulated by the reversible acetylation of specific, evolutionarily conserved lysine(s) in the protein. These results, suggest for the first time, that the mitochondria contain bidirectional post-translational signaling networks, similar to that observed in the cytoplasm and nucleus, and that changes in lysine acetylation alter MnSOD enzymatic activity. In addition, these new results demonstrate that the mitochondrial anti-aging or fidelity / sensing protein, SIRT3, responds to changes in mitochondrial nutrient and/or redox status to alter the enzymatic activity of specific downstream targets, including MnSOD that adjusts and/or maintains ROS levels as well as metabolic homeostatic poise.
Keywords: MnSOD, Sirt3, mitochondria, acetylation
One theme that has emerged in the last several years is that aging, perhaps better defined as longevity, is a complex genetic and cellular process that appears to be regulated, at least in part, by a relatively new gene family referred to as sirtuins [1,2]. These genes are the human and murine homologs of the Saccharomyces cerevisiae Sir2 that has been shown to regulate both replicative and overall lifespan [3,4]. The sirtuin family genes have also been shown to direct longevity in C. elegans and D. melanogaster [1,2] suggesting an evolutionary conserved need for these proteins in the cells in multiple different complex species. Sirtuins are classified as class III histone deacetylases, which are different than traditional class I and II histone deacetylases [5,6]. Unlike conventional HDACs, sirtuins have a variety of substrates ranging from metabolic enzymes to structural proteins as well as histones [7,8].
The mammalian sirtuin family consists of seven NAD+-dependent protein deacetylases [9-11] that share a common 275-amino acid catalytic domain and are localized to the nucleus (SIRT1, 6, and 7), mitochondria (SIRT3, 4, and 5), and cytoplasm (SIRT2), respectively [3]. Sirtuins require NAD+ as a cofactor which mechanistically connects their enzymatic activity to the metabolism of the cells, and provides link between the sirtuin activity and energy and stress responses [12,13]. Using these findings as a guide, it seems reasonable to suggest that sirtuins function as fidelity or watchdog proteins signaling proteins that alter the activity of downstream targets via post-translational modifications involving protein acetylation to maintain cellular metabolic homeostasis [14].
In this regard, lysine acetylation has recently emerged as an important, and perhaps the primary, post-translational modification employed to regulate mitochondrial proteins [14,15]. Several proteomic surveys have identified a disproportionately high number of acetylated proteins in the mitochondria and many of these proteins are associated with energy homeostasis [14,16]. Thus, these results suggest that the mitochondrial acetylome, which is regulated by both acetyl transferases as well as deacetylase such as sirtuins, may by the primary means by which the mitochondrial regulates energy production and ROS levels to match ATP production with intracellular energy requirements. In this regard, three of the seven mammalian sirtuins appear to be localized to the mitochondria [11], including SIRT3 that is the primary mitochondrial deacetylase [17], suggesting a significant role for these sirtuins in regulating mitochondrial metabolism [12,17]. Thus, we and others hypothesized that SIRT3 may act as a maintenance proteins that significantly determines the mitochondrial acetylome that functions by monitoring critical mitochondrial processes such as the regulation of respiration and/or metabolite clearance, and initiating a protective and/or reparative response.
Based on these results, it seems reasonable to propose that acetylation of mitochondrial proteins may play a role in maintaining and regulating mitochondrial ROS levels as well as function. Sirt3 is the main mitochondrial deacetylase [17], and genetic knockout of Sirt3 results in increased ROS, including superoxide levels, in vitro and in vivo [12]. Thus, we believe it is a logical extension to hypothesize that SIRT3 is a regulatory protein, maintaining mitochondrial homeostasis via changes in the acetylation of metabolic target proteins, including those comprising the mitochondrial ROS detoxification system.
We have previously demonstrated that MEFs lacking Sirt3 exhibit an immortalization permissive phenotype and the knockout mice spontaneously form well differentiated, estrogen and progesterone (ER/PR)-positive mammary tumors [18]. SIRT3 protein levels are decreased in human breast cancers as well as several other human malignancies [18] suggesting that SIRT3 is a genomically expressed, mitochondrial localized tumor suppressor. In addition, it has also been shown that the Sirt3 knockout mice are permissive for other age-related illnesses including fatty liver [13], insulin resistance [19], and cardiac hypertrophy [20,21]. These results identified Sirt3 as a more generalized mitochondrially fidelity protein and the mice lacking Sirt3 may be useful in vivo models to investigate human illnesses. One intriguing finding from all of these manuscripts is that cells lacking Sirt3 exhibited altered mitochondrial metabolism as exhibited by increased mitochondrial ROS and superoxide levels during stress. These results suggest that the aberrant regulation of the mitochondrial acetylome, which by definition occurs in murine cells lacking Sirt3, results in a phenotype permissive for mouse conditions that mimic human illness as well as suggest an underlying mechanism involving increased ROS and superoxide levels.
MnSOD as a Sirt3 deacetylation target that directs enzymatic detoxification activity
Manganese superoxide dismutase (MnSOD) is one of the primary mitochondrial antioxidant in a network of detoxification enzymes that neutralizes the highly reactive superoxide ions (O2-) to less reactive hydrogen peroxide (H2O2) followed by its immediate conversion to H2O by catalase and other peroxidases in the mitochondrial matrix [22]. Superoxide is the by-product of electron transport chains I and III while they work inefficiently, and arises as a primary damaging reagent for mtDNA and other mitochondrial macromolecules [19,23]. ROS, in order of sequential reduction from O2, include superoxide (O2-), hydrogen peroxide (H2O2), hydroxyl radical (.OH), and organic peroxides, that are normally produced during respiration [24]. While low amounts of ROS are natural side products of various electron transfer reactions and easily tolerated by the cell, abnormally high levels of ROS from any number of possible sources induces oxidative stress and can damage cells by peroxidizing lipids, and disrupting proteins and nucleic acids [25,26]. Since MnSOD enzymatically scavenges superoxide, which is increased in cells lacking Sirt3 [27], it seemed logical to suggest that cells lacking Sirt3 might have altered regulation of MnSOD activity.
The balance between the mitochondrial antioxidant detoxification system and ROS should be finely maintained while low levels mitochondrial ROS in are required by cells to modulate normal redox signaling networks. In addition, excessive amounts of ROS is believed to shortened life span [28] and induced age-associated pathological conditions, such as carcinogenesis, cardiovascular, and other diseases [29,30]. While MnSOD-/- mice are neonatal lethal the MnSOD+/- mice display higher oxidative damage and incidence of tumor formation [31,32]. Mutations in SOD2 were associated with human age-related disorders, such as cardiomyopathy, neuronal diseases, and cancer [33-36]. These results clearly demonstrate the significant role for the aberrant regulation of MnSOD in age-related illnesses and suggest that upstream signaling proteins that regulate MnSOD may also play a role in these pathologies as well.
There is an accumulating evidence that in specific solid tumors there is a very strong correlative statistically connection between aging as well as aberrant mitochondrial ROS regulation [37-39]. In this regard, the mice lacking Sirt3 appear to be an new in vivo model to investigate the connection between aging and carcinogenesis since these mice, at ages greater than 13 months, developed well differentiated ER/PR receptor positive mammary tumors, which is the subtype of breast cancer that is most commonly observed in postmenopausal women [18]. Kim and his colleagues proposed that increased mitochondrial superoxide level was one of the major reasons triggering breast tumor development in the older Sirt3 knockout mice. In addition to breast tissue, SirT3 deficient mouse hepatocytes and cardiomyocytes displayed significant mitochondrial superoxide levels [18,20]. Thus, it has been proposed that SIRT3 protects against ROS by enhancing the activity of antioxidant defense system, suggesting that this protein could be an imperative mitochondrial fidelity protein in the face of oxidative stress [18,20,40]. Based on these results our research group hypothesized that Sirt3 may bind to and regulate the enzymatic properties of MnSOD that detoxifies mitochondrial superoxide so as to prevent oxidative stress and cellular damage [41].
In this regard, we have recently shown in a manuscript published in Molecular Cell that MnSOD contains a reversibly acetylated lysine residue that is deacetylated by caloric restriction and 36 hours of fasting and MnSOD [41]. Purified MnSOD was also shown to be directly deacetylated by recombinant SIRT3 in an in vitro deacetylation assays and re-introduction of the wild-type, but not a deacetylation null, Sirt3 gene decreased MnSOD acetylation as well as increased MnSOD activity. These results strongly suggested that Sirt3 deacetylation activity directly directs MnSOD acetylation status as well as its enzymatic detoxification activity [41].
It was also shown that MnSOD physically interacts with Sirt3 and lysine 122 is deacetylated by Sirt3, suggesting that acetylation of this lysine, at least in part, may regulate MnSOD function. This idea was validated by a MnSOD mutant that demonstrated increased activity when lysine 122 was changed to arginine (to mimic the deacetylated state). MnSODK122-R decreased superoxide levels in MEFs lacking MnSOD as well as prevented IR-induced transformation of MnSOD-/- MEFs. Infection of MnSODK122-R into MEFs lackingSirt3 also decreased cellular superoxide levels and reversed the tissue culture immortalization / transformation permissive phenotype observed in these primary cells. These results suggest that MnSOD amino acid K122, which is conserved in multiple complex and primitive species, including C. elegans, directs MnSOD enzymatic detoxification activity as well as plays a role, at least in part, the damage permissive phenotype observed in murine cells lackingSirt3 [41]. Similar results for the role of Sirt3 regulation of MnSOD via acetylation has also be shown by the Chen laboratory [42] however, this group identified lysines 53 and 89 as acetylation targets that direct enzymatic function. Thus, this implies that MnSOD may contain additional reversible acetyl lysines that determine enzymatic activity.
In this manuscript we also showed livers from the Sirt3 knockout mice exposed to 2 Gy of radiation on two consecutive days demonstrated an ionizing radiation-induced damage permissive phenotype. This was determined by radiation-induced liver periportal to midzonal hepatocellular swelling, dilation of the cytoplasm, poorly defined vacuoles, and increased apoptosis and ROS, specifically ONOO-, a reaction product of nitric oxide and superoxide [41]. This histology displays some characteristics similar to, at least in part, to that observed in microvesicular steatosis that is associated with mitochondrial dysfunction [43]. Interestingly, the risk factors for steatosis include diabetes mellitus, protein malnutrition, and obesity [43], all of which have been associated with abnormalities of Sirtuin function [11]. These results suggest an oxidative stress permissive phenotype, including increase cellular superoxide levels, in liver cells lacking Sirt3. These results as well as those observed by others for fatty liver [13], insulin resistance [19], and cardiac hypertrophy [20,21] clearly show that the mice lacking Sirt3 exhibit a cell damage permissive phenotype for age-related illnesses and strongly suggest a mechanisms involving aberrant accumulation of mitochondrial superoxide levels. Finally, while the data does not definitively show that the aberrant acetylation a subsequent regulation of MnSOD is causative in these pathological processes, these results do make a strong potential scientific argument for altered regulation of MnSOD.
Figure 1.
Figure 1.
Proposed model figure describing Sirt3 acetylation and subsequent regulation of MnSOD detoxification enzymatic activity.
The results discussed above suggest that loss of a single mitochondrial protein and the aberrant regulation of the mitochondrial acetylome signaling network that responds to metabolic demands and deacetylates downstream target proteins results in a phenotype permissive for human illnesses associated with aging. In this regard, MnSOD as well as several other recently identified mitochondrial proteins such as acetyl-CoA synthetase [15,44], glutamate dehydrogenase GDH) [44,45], long-chain acyl-CoA dehydrogenase (LCAD) [46], succinate Dehydrogenase [47], Ku70 [20], mitochondrial ribosome subunit MRPL10 [48], and isocitrate dehydrogenase [49]. These Sirt3 targets all appear to regulate critical mitochondrial enzymes that regulate energy metabolism and very strongly suggested that Sirt3 is a mitochondrial metabolism sensing protein maintains energy homeostasis responding to specific nutrient and environmental conditions. As such, we believe the Sirt3 knockout mice represent a new paradigm that mechanistically links mitochondrial metabolism, the acetylome post-translation signaling network, and age-related disease including ER/PR breast cancer carcinogenesis, radiation-induced liver steatosis, fatty liver, insulin resistance, cardiac hypertrophy, and neurodegenerative diseases.
Acknowledgments
DG is supported by 1R01CA152601-01 from the NCI, BC093803 from the DOD, and SPORE P50CA98131. DRS and MCC were supported by grants from the NIH and DOE (R01CA133114, T32CA078586, P30CA086862, and DE-SC0000830).
  • Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A. 2004;101:15998–16003. [PubMed]
  • Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004;430:686–689. [PubMed]
  • Hallows WC, Albaugh BN, Denu JM. Where in the cell is SIRT3?-functional localization of an NAD+-dependent protein deacetylase. Biochem J. 2008;411:e11–13. [PMC free article] [PubMed]
  • Hursting S D, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annual review of medicine. 2003;54:131–152. [PubMed]
  • Saunders LR, Verdin E. Cell biology. Stress response and aging. Science. 2009;323:1021–1022. [PubMed]
  • Donmez G, Guarente L. Aging and disease: connections to sirtuins. Aging Cell. 2010;9:285–290. [PubMed]
  • Guarente L, Partridge L, Wallace DC. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2008. Molecular biology of aging.
  • Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell metabolism. 2008;7:104–112. [PubMed]
  • Guarente L, Picard F. Calorie restriction--the SIR2 connection. Cell. 2005;120:473–482. [PubMed]
  • Guarente L. Mitochondria--a nexus for aging, calorie restriction, and sirtuins? Cell. 2008;132:171–176. [PMC free article] [PubMed]
  • Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460:587–591. [PubMed]
  • Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci U S A. 2008;105:14447–14452. [PubMed]
  • Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV, Jr, Alt FW, Kahn CR, Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 2010;464:121–125. [PMC free article] [PubMed]
  • Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325:834–840. [PubMed]
  • Schwer B, Bunkenborg J, Verdin RO, Andersen JS, Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci U S A. 2006;103:10224–10229. [PubMed]
  • Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, Zhao Y. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Molecular cell. 2006;23:607–618. [PubMed]
  • Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RV, Jr, Weissman S, Verdin E, Schwer B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol Cell Biol. 2007;27:8807–8814. [PMC free article] [PubMed]
  • Kim H S, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress. Cancer cell. 2010;17:41–52. [PubMed]
  • Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS. Endurance exercise as a countermeasure for aging. Diabetes. 2008;57:2933–2942. [PMC free article] [PubMed]
  • Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP. SIRT3 is a stress responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku-70. Mol Cell Biol. 2008 [PMC free article] [PubMed]
  • Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. The Journal of clinical investigation. 2009 [PMC free article] [PubMed]
  • Oberley LW, Oberley TD. Role of antioxidant enzymes in cell immortalization and transformation. Mol Cell Biochem. 1988;84:147–153. [PubMed]
  • Henderson JR, Swalwell H, Boulton S, Manning P, McNeil CJ, Birch-Machin MA. Direct, real-time monitoring of superoxide generation in isolated mitochondria. Free Radic Res. 2009;43:796–802. [PubMed]
  • Spitz DR, Adams DT, Sherman CM, Roberts RJ. Mechanisms of cellular resistance to hydrogen peroxide, hyperoxia, and 4-hydroxy-2-nonenal toxicity: the significance of increased catalase activity in H2O2-resistant fibroblasts. Arch Biochem Biophys. 1992;292:221–227. [PubMed]
  • Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91:31S–38S. [PubMed]
  • Spitz DR, Li GC. Heat-induced cytotoxicity in H2O2-resistant Chinese hamster fibroblasts. J Cell Physiol. 1990;142:255–260. [PubMed]
  • Spitz DR, Oberley LW. An assay for superoxide dismutase activity in mammalian tissue homogenates. Analytical biochemistry. 1989;179:8–18. [PubMed]
  • Sebastian C, Mostoslavsky R. SIRT3 in calorie restriction: can you hear me now? Cell. 2010;143:667–668. [PubMed]
  • Merry BJ. Oxidative stress and mitochondrial function with aging--the effects of calorie restriction. Aging Cell. 2004;3:7–12. [PubMed]
  • Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005;120:483–495. [PubMed]
  • Zhang Y, Zhang HM, Shi Y, Lustgarten M, Li Y, Qi W, Zhang BX, Van Remmen H. Loss of manganese superoxide dismutase leads to abnormal growth and signal transduction in mouse embryonic fibroblasts. Free Radic Biol Med. 2010;49:1255–1262. [PMC free article] [PubMed]
  • Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R, Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics. 2003;16:29–37. [PubMed]
  • Epperly MW, Epstein CJ, Travis EL, Greenberger JS. Decreased pulmonary radiation resistance of manganese superoxide dismutase (MnSOD)-deficient mice is corrected by human manganese superoxide dismutase-Plasmid/Liposome (SOD2-PL) intratracheal gene therapy. Radiat Res. 2000;154:365–374. [PubMed]
  • Van Remmen H, Williams MD, Guo Z, Estlack L, Yang H, Carlson EJ, Epstein CJ, Huang TT, Richardson A. Knockout mice heterozygous for Sod2 show alterations in cardiac mitochondrial function and apoptosis. Am J Physiol Heart Circ Physiol. 2001;281:H1422–1432. [PubMed]
  • Van Remmen H, Qi W, Sabia M, Freeman G, Estlack L, Yang H, Guo Mao, Huang TT, Strong R, Lee S, Epstein CJ, Richardson A. Multiple deficiencies in antioxidant enzymes in mice result in a compound increase in sensitivity to oxidative stress. Free Radic Biol Med. 2004;36:1625–1634. [PubMed]
  • Fishman K, Baure J, Zou Y, Huang TT, Andres-Mach M, Rola R, Suarez T, Acharya M, Limoli CL, Lamborn KR, Fike JR. Radiation-induced reductions in neurogenesis are ameliorated in mice deficient in CuZnSOD or MnSOD. Free Radic Biol Med. 2009 [PMC free article] [PubMed]
  • Ershler WB, Longo DL. The biology of aging: the current research agenda. Cancer. 1997;80:1284–1293. [PubMed]
  • Ershler WB, Longo DL. Aging and cancer: issues of basic and clinical science. Journal of the National Cancer Institute. 1997;89:1489–1497. [PubMed]
  • Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, Cohen P, Longo VD. Fasting and cancer treatment in humans: A case series report. Aging (Albany NY) 2009;1:988–1007. [PMC free article] [PubMed]
  • Jacobs KM, Pennington JD, Bisht KS, Aykin-Burns N, Kim HS, Mishra M, Sun L, Nguyen P, Ahn BH, Leclerc J, Deng CX, Spitz DR, Gius D. SIRT3 interacts with the daf-16 homolog FOXO3a in the Mitochondria, as well as increases FOXO3a Dependent Gene expression. International journal of biological sciences. 2008;4:291–299. [PMC free article] [PubMed]
  • Tao R, Coleman MC, Pennington JD, Ozden O, Park SH, Jiang H, Kim HS, Flynn CR, Hill S, Hayes McDonald W, Olivier AK, Spitz DR, Gius D. Sirt3-Mediated Deacetylation of Evolutionarily Conserved Lysine 122 Regulates MnSOD Activity in Response to Stress. Molecular cell. 2010;40:893–904. [PMC free article] [PubMed]
  • Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell metabolism. 2010;12:662–667. [PubMed]
  • Araya QA, Valera MJ, Contreras BJ, Csendes JA, Diaz JJ, Burdiles PP, Rojas CJ, Maluenda GF, Smok SG, Poniachik TJ. [Glucose tolerance alterations and frequency of metabolic syndrome among patients with non alcoholic fatty liver disease] Rev Med Chil. 2006;134:1092–1098. [PubMed]
  • Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci U S A. 2006;103:10230–10235. [PubMed]
  • Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CF, Steegborn C. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol. 2008;382:790–801. [PubMed]
  • Hirschey MD, Shimazu T, Huang JY, Verdin E. Acetylation of mitochondrial proteins. Methods Enzymol. 2009;457:137–147. [PubMed]
  • Cimen H, Han MJ, Yang Y, Tong Q, Koc H, Koc EC. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry. 2010;49:304–311. [PMC free article] [PubMed]
  • Yang Y, Cimen H, Han MJ, Shi T, Deng JH, Koc H, Palacios OM, Montier L, Bai Y, Tong Q, Koc EC. NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J Biol Chem. 2010;285:7417–7429. [PubMed]
  • Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010;143:802–812. [PMC free article] [PubMed]
Articles from Aging (Albany NY) are provided here courtesy of
Impact Journals, LLC